Skip to main content
NCBI home page
PLOS One logoLink to PLOS One
. 2021 Feb 4;16(2):e0246436. doi: 10.1371/journal.pone.0246436

Bivariate genome-wide association study (GWAS) of body mass index and blood pressure phenotypes in northern Chinese twins

Zhaoying Li 1, Weijing Wang 1, Xiaocao Tian 2,3, Haiping Duan 2,3, Chunsheng Xu 2,3, Dongfeng Zhang 1,*
Editor: Yuan-Ming Zhang4
PMCID: PMC7861438  PMID: 33539483

Abstract

Recently, new loci related to body mass index (BMI) or blood pressure (BP) have been identified respectively in genome-wide association studies (GWAS). However, limited studies focused on jointly associated genetic variance between systolic pressure (SBP), diastolic pressure (DBP) and BMI. Therefore, a bivariate twin study was performed to explore the genetic variants associated with BMI-SBP, BMI-DBP and SBP-DBP. A total of 380 twin pairs (137 dizygotic pairs and 243 monozygotic pairs) recruited from Qingdao Twin Registry system were used to access the genetic correlations (0.2108 for BMI-SBP, 0.2345 for BMI-DBP, and 0.6942 for SBP-DBP, respectively) by bivariate Cholesky decomposition model. Bivariate GWAS in 137 dizygotic pairs nominated 27 single identified 27 quantitative trait nucleotides (QTNs) for BMI and SBP, 27 QTNs for BMI and DBP, and 25 QTNs for SBP and DBP with the suggestive P-value threshold of 1×10−5. After imputation, we found eight SNPs, one for both BMI-SBP and SBP-DBP, and eight for SBP-DBP, exceed significant statistic level. Expression quantitative trait loci analysis identified rs4794029 as new significant eQTL in tissues related to BMI and SBP. Also, we found 6 new significant eQTLs (rs4400367, rs10113750, rs11776003, rs3739327, rs55978930, and rs4794029) in tissues were related to SBP and DBP. Gene-based analysis identified nominally associated genes (P < 0.05) with BMI-SBP, BMI-DBP, and SBP-DBP, respectively, such as PHOSPHO1, GNGT2, KEAP1, and S1PR5. In the pathway analysis, we found some pathways associated with BMI-SBP, BMI-DBP and SBP-DBP, such as prion diseases, IL5 pathway, cyclin E associated events during G1/S transition, TGF beta signaling pathway, G βγ signaling through PI3Kγ, prolactin receptor signaling etc. These findings may enrich the results of genetic variants related to BMI and BP traits, and provide some evidences to future study the pathogenesis of hypertension and obesity in the northern Chinese population.

Introduction

Hypertension and obesity are public health challenges worldwide [1, 2]. Hypertension increases the risk of several diseases, such as chronic renal disease, stroke, dementia and coronary artery disease, etc. [3–7]. Obesity is related to cardiovascular disease, diabetes, cancer and increase global burden worldwide [8–10]. Both of hypertension and obesity are complex chronic diseases effected by genetic and environmental factors [11, 12]. SBP, DBP and BMI are important anthropometric measurements of hypertension and obesity, respectively. A systemic review reported the estimated heritability of SBP ranging from 17% to 52%, and DBP from 19% to 41% [13]. Another review estimated the heritability of BMI from 47% to 90% [14]. There were some mechanisms linking obesity with hypertension, such as sympathetic nervous system activation, hypothalamic-pituitary axis dysregulation, insulin resistance/hyperinsulinemia, and renin-angiotensin-aldosterone system activation [15, 16]. Several twin studies previously presented multivariate modeling of BMI and BP to explore their common genetic and environmental background [17, 18]. And it was demonstrated that the genetic correlation between BMI and BP ranged from 0.15 to 0.49, and additive genetic factors accounted for 65%-86% of the phenotypic correlations between BMI and BP components [19–23].

Genome-wide association studies (GWAS) are used to nominate loci for complex diseases [24]. Recently, new loci related to BMI or BP have been identified in GWAS [25–27]. However, all associated loci can only explain 2.7% of total variance of BMI, 2–3% of SBP, and 1.3–2.6% of DBP [28, 29]. Therefore, more causal loci need to be found. Univariate GWAS has been conducted with single trait that failed to take into account clinical relatedness and correlation among phenotypes. Multivariate GWAS has higher power outperforming univariate approach to explore more single nucleotide polymorphisms (SNPs) and pleiotropic genes potentially related to correlated phenotypes [30, 31]. A key advantage of it is to demonstrate how genetic variants effect on correlated phenotypes directly, instead of coincidental overlap of two traits. Several bivariate analyses of SBP and DBP demonstrated some SNPs located in chromosomes 3 and 9 [32]. Also, some pathways were found associated with BMI and BP [29, 33]. However, limited bivariate GWAS about BMI and BP phenotypes were conducted in the northern Chinese population. And genetic variance and genes potentially related to hypertension and obesity still remain unknown, and thus need further exploration. Therefore, we designed this bivariate twin study to: (1) identify genetic variants associated with BMI-SBP, BMI-DBP and SBP-DBP, respectively; and (2) identify potential causal genetic variation; (3) determine the common pathways associated with hypertension and obesity.

Methods

Twin samples

The participants were recruited from Qingdao twin registry system by internet, newspaper and local community hospital. More details of recruitment have described in literatures [34, 35]. Questionnaire data and examination data were collected from all twin samples. The participants were included if: they were 18 years old and over; questionnaire data, examination data and laboratory data were available; and twin pairs can be followed up. The participants were excluded if: they were in pregnant or in lactation; with serious illness or cognitive impairment; taking anti-hypertensive or lose-weight medicine within one month, as well as the incomplete twin pairs. 380 pairs of eligible twin samples (243 pairs of monozygotic (MZ) twin and 137 dizygotic (DZ) twins) were included. Zygosity was identified by sex, blood type and DNA markers at Qingdao Blood Center. This study has been approved by the Regional Ethics Committee of the Qingdao CDC Institutional Review Boards.

Phenotypes

BMI was defined as an individual’s body weight in kilograms divided by the square of his/her height in meters (kg/m2). Blood pressure was taken by a standard procedure using mercurial table stand model sphygmomanometer. Systolic blood pressure was defined as Korotkoff of phase I (appearance of sound), and diastolic blood pressure was defined as Korotkoff phase V (disappearance of sound). Average values were used after three measurement.

Genotyping, quality control, and imputation

137 DZ pairs was genotyped using Infinium Omni2.5Exome-8v1.2 BeadChip (Illumina, SanDiego, California, USA) on autosomes. Ultimately, 1,338,796 SNPs from 274 samples were analyzed in this bivariate GWAS according to inclusion criteria (Calling rate > 0.98; minor allele frequency, MAF > 0.05; Hardy-Weinberg, Hwe significance > 1×10−4; locus missing <0.05) [20].

To identify new risk variants, IMPUTE 2 [36] software was performed to impute typed SNPs using 1,000 Genomes Project Phase 3 as the reference panel (105 Han Chinese South samples, and 103 Han Chinese Beijing samples) [37] according to Linkage Disequilibrium (r2 >0.6), MAF>0.05, and Hwe>1×10−4. Finally, 7,401,356 SNPs were included in this study.

Statistical analysis

Heritability

Bivariate Cholesky decomposition model [38] was used to assess the genetic and environmental effects on phenotypic correlation between BMI and BP using Mx software package (http://www.vcu.edu/mx) with age and sex adjusted. Due to the deviation of the distribution, the Blom’s formula was used to guarantee the normal distribution or approximate normal distribution. Bivariate Cholesky model decomposed variations for both phenotype into additive genetic (A), common (shared) environmental (C), and unique /non-shared environmental (E) variance. Nested models were conducted by dropping A (CE model) or C (AE model) after fitting the full model (ACE). The likelihood ratio χ2 tests compared whether the full model and nested model has significant difference [38, 39]. The parsimonious model was chosen according to lower Akaike’s Information Criterion (AIC) as the best fitting model [40].

Genotyping, GWAS and conditional analysis

The genome-wide efficient mixed-model association (GEMMA) [41] was applied Genetic relatedness matrix and Bayesian sparse linear mixed model [42] were performed to estimate associations between genetic variance and phenotypic pairs in SNP-based analysis of BMI-SBP, BMI-DBP and SBP-DBP for 137 DZ twins, with age and sex adjusted. The conventional Bonferroni-corrected threshold of P < 5 × 10−8 was adopted as significant threshold [43, 44], and the commonly used threshold of P < 1 × 10−5 as a suggestive evidence level [45, 46]. When none SNPs reaches significant threshold, suggestive evidence level was applied to find more SNPs. Quantile-Quantile plot (Q-Q plot) depicted and compared the distribution of observed P- values of SNPs against the expected P- values. The genomic inflation factor λ revealed if there was evidence of inflation of test statistics due to population stratification. Manhattan plots provided a compact visual way of demonstrating P- values of SNPs ordered by chromosome on the x axis. PLINK software was used to perform conditional analysis on GWAS data to identify independently associated variants [47]. The region containing top variant with ±5 Mb upstream and downstream was selected. And we re- evaluated each variant conditioning on the top variant. Then we repeated this process and tested whether still significant variants associated with phenotypic pairs. The conditional analysis consists of a new group of much less tests compared to the unconditional analysis, therefore, a separate P-value of 0.001 was adopted as significant threshold.

Expression quantitative trait loci (eQTL) analysis

Expression quantitative trait loci has been widely used to uncover effect of genetic variants on phenotypes [48, 49]. To determine the potential causal SNPs related to blood pressure and BMI, we queried relative SNPs and genes on Haploreg V4.1 (http://pubs.broadinstitute.org/mammals/haploreg/haploreg.php) (Accessed data: November, 2020; Last Update Date: 5th, November, 2015) [50] and publicly available eQTL data from Genotype-Tissue Expression (GTEx) Project (https://www.gtexportal.org/home/) (Accessed data: November, 2020; Latest Data Release: V8) [51]. cis-eQTLs were identified in adipose-subcutaneous, artery-aorta, artery-coronary, artery-tibial, brain-cerebellar-hemisphere, heart-atrial appendage, and heart-left ventricle tissue.

Gene-based analysis

We used VEGAS 2 [52, 53] to determine the association between specific genes and phenotypic pairs. All of the SNPs were from “1000G East ASIAN” sample. As we obtained 19001 genes, a P- value below 2.63×10−6 (0.05/19001) was considered to be genome-wide significant. P- value below 0.05 was considered as nominal significance threshold [54].

Pathway enrichment analysis

PASCAL programme was used to calculate pathway-scored [55]. The genetic markers SNPs were firstly mapped to genes, then pathway scores were calculated through combining corresponding gene scores. Pathways with high scores were selected and evaluated by chi-squared or empirical score. Pathways and corresponding annotation can be obtained from KEGG, Reactome, and Biocarta.

Results

The characteristics of eligible participants are shown in Table 1. A total of 380 twin pairs are identified, including 137 dizygotic pairs. 380 twin pairs are used in heritability analysis. The mean age of participants is 51.5±7.6 years; the mean BMI is 24.3±3.3 kg/m2, and mean SBP and DBP are 130.8±20.1mmHg and 83.1±10.9mmHg, respectively. 137 DZ pairs were used in GWAS with mean age of 51.0±7.2 years, mean BMI of 24.6±3.1 kg/m2, and mean SBP and DBP of 132.5±20.2mmHg and 84.1±10.5mmHg, respectively.

Table 1. Characteristics of participants by sex.

Variable All Female Male
Mean±SD N Mean±SD N Mean±SD N
380 twin pairs Age(year) 51.5±7.6 760 50.9±6.7 392 52.1±8.5 368
BMI(kg/m2) 24.3±3.3 760 24.3±3.4 392 24.3±3.1 368
SBP(mmHg) 130.8±20.1 760 126.2±19.9 392 135.6±19.1 368
DBP(mmHg) 83.1±10.9 760 80.2±9.9 392 86.1±11.0 368
137 DZ pairs Age(year) 51.0±7.2 274 51.1±7.1 136 50.8±7.3 140
BMI(kg/m2) 24.6±3.1 274 24.5±3.2 136 24.7±3.0 140
SBP(mmHg) 132.5±20.2 274 129.6±20.7 136 135.3±19.4 140
DBP(mmHg) 84.1±10.5 274 81.9±9.9 136 86.2±10.7 140
Open in a new tab

Heritability analysis

The phenotypic correlation of BMI-SBP, BMI-DBP, and SBP-DBP are 0.214, 0.256, and 0.684, respectively under the best fitting model AE (S1 Table). Genetic correlations are 0.2108, 0.2345, and 0.6942, respectively (Table 2). The standardized path coefficients from best fitting AE model are presented in Fig 1.

Table 2. Estimated genetic and environmental correlations and phenotypic correlation between traits.

Phenotypic pairs rG(95% CI) rC(95% CI) rE(95% CI) Phenotypic correlation
Full model
BMI-SBP 0.3299(-0.0694,0.7262) -1(-1,1) 0.2302(0.1102,0.3437) 0.211
BMI-DBP 0.2082(-02678,0.6084) -1(-1,1) 0.3218(0.2077,0.4274) 0.256
SBP-DBP 0.8604(0.3403,1) 0.3488(-1,1) 0.6627(0.5870,0.7268) 0.683
Best fitting Model
BMI-SBP 0.2108(0.0843,0.3302)* - 0.2360(0.1194,0.3462)* 0.214
BMI-DBP 0.2345(0.1027,0.3571)* - 0.3183(0.2067,0.4218)* 0.256
SBP-DBP 0.6942(0.6006,0.7698)* - 0.6728(0.6031,0.7323)* 0.684
Open in a new tab

rG: Genetic correlation; rC: Shared environmental correlation; rE: Non-shared environmental correlation.

∗: p < 0.05.

Fig 1.

Fig 1

Open in a new tab

Best bivariate model (AE model) for BMI-SBP (A), BMI-DBP (B), and SBP-DBP (C) with standardized path coefficients. A1, A2: genetic variance components; E1, E2: unique environmental variance components; a11 through a22: genetic path coefficients, of which a22 demonstrates specific genetic influence on BP. e11 through e22: unique environmental path coefficients, of which e22 demonstrates specific unique environmental influence on BP.

Bivariate GWA analysis

SNP-based analysis, imputation and conditional analysis

A total of 1,338,796 eligible SNPs from 137 DZ twin pairs are included in bivariate GWA analysis. Q-Q plot (Fig 2) indicated no evidence of genomic inflation of test statistics or the bias from the population stratification. As illustrated in Manhattan plot (Fig 3), 27 SNPs of both BMI-SBP and BMI-DBP, and 25 SNPs of SBP-DBP reached suggestive evidence level (P < 1 × 10−5), although none of the SNPs exceeded statistically significant level (P<5×10−8).

Fig 2.

Fig 2

Open in a new tab

Q-Q plot for SNP associations with BMI-SBP (A), BMI-DBP (B), and SBP-DBP (C). The red line represents the expected value under the null distribution. The x- axis shows the expected -log10 P-values, while y-axis shows the observed -log10 P-values. The gray shaded gives the 95% acceptance region. N refers to the number of SNPs. λ refers to genomic inflation.

Fig 3. Manhattan plot of individual SNP associations with BMI-SBP, BMI-DBP, and SBP-DBP.

Fig 3

Open in a new tab

Manhattan plot depicts the individual SNP ordered by chromosome. The x- axis shows the order of chromosome, while y-axis shows the P-values of SNPs. The red line indicates genome-wide significance level (5×10−8), and the horizontal lower line indicates suggestive evidence level (1 × 10−5).

Among top signals associated with BMI-SBP, the strongest associated SNP is rs200126670 (P = 2.94×10−7). Ten SNPs near LINC00343 gene located on chromosome 13q33.2 (S2 Table). Among top signals associated with BMI-DBP, the strongest associated SNP is rs2025924 (P = 3.41×10−7). Eleven SNPs near LINC00343 gene were located on chromosome 13q33.2. Two SNPs at SLC39A11 gene located on chromosome 17q24.3-q25.1 (S3 Table). Among top signals associated with SBP-DBP, the strongest associated SNP is rs113511958 (P = 5.14×10−7). Three SNPs near LINC00624 gene were located on chromosome 1q21.1-q21.2. And two SNPs at TRAPPC9 gene were located on chromosome 8q24.3 (S4 Table). Moreover, rs4794029 is related with BMI-SBP, BMI-DBP, and SBP-DBP.

After imputation, more risk variants are identified (Fig 4). One SNP related to BMI-SBP, and eight SNPs related to SBP-DBP reached significant statistic level. However, still no SNPs associated with BMI-DBP exceeds the significant threshold (Table 3).

Fig 4. Manhattan plot of individual SNP associations with BMI-SBP, BMI-DBP, and SBP-DBP after imputation.

Fig 4

Open in a new tab

For details see Fig 3.

Table 3. SNPs that reached P < 5×10−8 from bivariate GWAS of BMI-SBP, BMI-DBP and SBP-DBP after imputation.
SNP Chr. Position(bp) P-value Gene/Nearest gene
BMI-SBP
7:19534588 (rs540063109) 7 19534588 2.06E-08 TMEM196
SBP-DBP
rs61118809 11 78630891 6.84E-10 TENM4
rs5792827 11 78645913 9.14E-09 TENM4
rs5013388 11 78646117 9.14E-09 TENM4
rs79840843 11 78643557 1.04E-08 TENM4
rs57611205 11 78645171 1.34E-08 TENM4
rs673456 11 78629612 1.42E-08 TENM4
rs12419933 11 78630596 2.07E-08 TENM4
7:19534588 (rs540063109) 7 19534588 2.90E-08 TMEM196
Open in a new tab

Chr, chromosome. bp: base pair.

To eliminate the effects of linkage disequilibrium and identify independently associated variants, we re-evaluated each variant conditioning on the top variant, which located at chromosome 1, 13, and 5, respectively (S1–S3 Figs).

Expression quantitative trait loci (eQTL) analysis

We queried SNPs from S2–S4 Tables and Table 3 with LD threshold r2>0.8 and Asian population referenced. Among them, rs4794029 located on 17q21.32 was the significant eQTL in three tissues (Adipose-Subcutaneous (P = 8.4×10−8), Heart-Atrial Appendage (P = 1×10−6), and Heart-Left Ventricle (P = 2.5× 10−5)) related to BMI and SBP. As for SBP and DBP, we found significant eQTLs located on 17q21.32 and 8q12.1 that related to blood pressure, such as rs4400367, the significant eQTL in several tissues (Heart-Atrial Appendage (P = 2.7×10−14), and Heart-Left Ventricle(P = 7.3×10−12), Artery-Aorta(P = 1.2×10−6, P = 1.3×10−5), and Artery-Tibial (P = 1.7× 10−5)). However, none significant eQTL was found in tissues related to BMI and DBP (Table 4).

Table 4. P-values of SNPs in different tissues related to BMI-SBP, and SBP-DBP.
SNP ID Tissue Site Detail P-Value Gene Symble
BMI and SBP
rs4794029 Adipose—Subcutaneous 8.40E-08 GNGT2
Heart—Atrial Appendage 1.00E-06 GNGT2
Heart—Left Ventricle 2.50E-05 GNGT2
Artery—Aorta 9.50E-05 GNGT2
SBP and DBP
rs4400367 Heart—Atrial Appendage 2.70E-14 SDCBP
Heart—Left Ventricle 7.30E-12 SDCBP
Artery—Aorta 1.20E-06 NSMAF
Artery—Aorta 1.30E-05 SDCBP
Artery—Tibial 1.70E-05 CYP7A1
rs10113750 Heart—Atrial Appendage 6.90E-15 SDCBP
Heart—Left Ventricle 2.00E-12 SDCBP
Artery—Tibial 4.50E-06 CYP7A1
Artery—Aorta 5.70E-06 NSMAF
Artery—Aorta 1.30E-07 SDCBP
rs11776003 Heart—Atrial Appendage 1.40E-15 SDCBP
Heart—Atrial Appendage 1.40E-15 SDCBP
Heart—Left Ventricle 3.60E-12 SDCBP
Artery—Aorta 1.40E-07 SDCBP
rs3739327 Heart—Atrial Appendage 3.30E-14 SDCBP
Heart—Left Ventricle 2.10E-11 SDCBP
Artery—Aorta 1.60E-06 NSMAF
Artery—Aorta 1.40E-05 SDCBP
Artery—Tibial 2.00E-05 CYP7A1
rs55978930 Heart—Atrial Appendage 2.90E-05 GNGT2
rs4794029 Heart—Atrial Appendage 1.00E-06 GNGT2
Heart—Left Ventricle 2.50E-05 GNGT2
Artery—Aorta 9.50E-05 GNGT2
Open in a new tab

Gene-based analysis

We found no genes exceeding the statistically significant level (2.63×10−6). However, 1043 genes of BMI-SBP, 1103 genes of BMI-DBP, and 1100 genes of SBP-DBP reached suggestive evidence level (P < 0.05). PHOSPHO1 is related to both BMI-SBP and BMI-DBP with smallest P- value. Top 10 genes are displayed in Table 5 ordered by P- value.

Table 5. Top 10 genes that reached P<0.05 from bivariate GWAS of BMI-SBP, BMI-DBP and SBP-DBP.
Gene Chr. SNP(n) From To P
BMI-SBP
PHOSPHO1 17 2 47300731 47308128 6.00E-06
GNGT2 17 5 47283595 47287936 6.00E-06
KEAP1 19 5 10596795 10614054 6.40E-05
NAP1L1 12 11 76438671 76478738 1.53E-04
ABI3 17 8 47287588 47300587 1.65E-04
PSMB3 17 5 36908965 36920484 1.89E-04
PFKFB3 10 131 6186842 6277507 2.17E-04
TP53I13 17 2 27895738 27900175 2.34E-04
S1PR5 19 4 10623417 10628668 2.39E-04
THRB 3 317 24158644 24536313 2.75E-04
BMI-DBP
PHOSPHO1 17 2 47300731 47308128 1.10E-05
GNGT2 17 5 47283595 47287936 2.40E-05
LINC00346 13 6 111516333 111522655 2.80E-05
KEAP1 19 5 10596795 10614054 6.20E-05
FMO9P 1 8 166573152 166594473 8.10E-05
TFF2 21 3 43766466 43771208 1.35E-04
TP53I13 17 2 27895738 27900175 1.75E-04
FEV 2 2 219845808 219850379 1.84E-04
FBLIM1 1 12 16085254 16113084 2.31E-04
MRPS28 8 28 80831094 80942506 2.62E-04
SBP-DBP
LINC00346 13 6 111516333 111522655 4.00E-05
TFF2 21 3 43766466 43771208 9.20E-05
SLC37A4 11 7 118895060 118901616 2.00E-04
TRAPPC4 11 3 118889240 118894385 2.06E-04
LOC339593 20 12 11247306 11254031 2.18E-04
LINC01158 2 14 105421882 105467934 2.23E-04
S100A9 1 2 153330329 153333503 2.30E-04
CLIP4 2 45 29320541 29406679 2.32E-04
TREML2 6 14 41157486 41168925 2.37E-04
REM2 14 3 23352431 23356889 2.38E-04
Open in a new tab

Chr, chromosome.

In addition, above mentioned genes were queried in GTEx, and then number of significant eQTLs in interest tissues were displayed in S5 Table.

Pathway enrichment analysis

628 pathways were significantly associated with BMI-SBP, 599 with BMI-DBP, and 766 with SBP-DBP (P < 0.05), such as prion diseases, IL5 pathway, and Cyclin E associated events during G1/S transition, respectively. TGF beta signaling pathway, G βγ signaling through PI3Kγ, prolactin receptor signaling, ADP signaling through P2RY1 pathway etc. More details of top 20 pathways are displayed in S6 Table.

Discussion

We conducted the first bivariate GWAS of joint BMI and BP phenotypes in northern Chinese population. This investigation included 380 twin pairs with mean age of 51.5±7.6 years; mean BMI of 24.3±3.3 kg/m2, and mean SBP and DBP of 130.8±20.1mmHg and 83.1±10.9mmHg, respectively. Bivariate structural equation models indicated a genetic component in phenotypic correlation between BMI and BP. The significant genetic correlation of BMI-SBP, BMI-DBP, and SBP-DBP were 0.2108, 0.2345, and 0.6942, respectively. Previous studies proved the genetic correlation between BMI and BP range from 0.15 to 0.49 [22, 56]. Therefore, the pleiotropic gene variants related to both BMI and BP need to be further explored.

This current GWAS identified 6 potential causal SNPs. rs4794029 may affect the gene expression level of GNGT2 on BMI and SBP. GNGT2 was reported to be involved in inflammatory and immune responses through mediating β-arrestin 1-induced Akt phosphorylation and NFκB activation [57, 58]. We identified 6 SNPs in result of SBP and DBP. Of which, 3 eQTLs (rs4400367, rs10113750, rs3739327) effect NSMAF on gene expression level. NSMAF plays a pro-apoptotic role in tumor necrosis factor (TNF) delivering immune signals [59]. Also, lack of NSMAF result in a decrease in expression of interleukin 6 and various chemokines important in immunoregulation [60]. CYP7A1 encodes a member of the cytochrome P450 superfamily of enzymes. Cytochrome (CYP) P450 metabolites of arachidonic acid contribute to the control of BP [61]. Previous studies confirmed other member of cytochrome P450 family such as CYP17A1-CNNM2, CYP17A1, CYP1A2 genes associated with BP in Japanese and European population [25, 62].

In gene-based analysis, nine genes (PHOSPHO1, GNGT2, KEAP1, S1PR5 etc.) were associated with both BMI-SBP and BMI-DBP. PHOSPHO1 up-regulated express in rabbit models with hyperlipidemia and atherosclerosis [63]. Also, it has been proved that DNA methylation at PHOSPHO1 in blood associated with type 2 diabetes risk [64, 65]. KEAP1 protein is one of key redox-sensitive signaling proteins mediating the response to oxidant stress, which inhibit regulator of transcription factor Nuclear factor-erythroid 2 p45-related factor 2 (Nrf2) [66]. The absence of Nrf2 could protect against weight gain and obesity [67]. S1PR5 encodes one of receptors of sphingosine 1-phosphate (S1P), which activate the endothelial isoform of nitric-oxide synthase (eNOS) [68]. As a key signaling protein, eNOS promote relaxation of vascular smooth muscle and inhibit platelet aggregation [69].

In pathways enrichment analysis, 628 pathways were identified significant association with BMI-SBP, 599 pathways with BMI-DBP, and 766 pathways with SBP-DBP. Some of them were biologically plausible. G βγ signaling through PI3Kγ was found associated with BMI-DBP. The lipid kinase PI3Kγ, as a central proinflammatory signal transducer, proposed a role in obesity-induced inflammation and insulin resistance in hematopoietic cells [70, 71]. Previous research indicated the increasing PI3Kγ in insulin-resistant obese subjects. Meanwhile, PI3Kγ participants in physiological process of vascular smooth muscle cells [72]. Prolactin receptor signaling was found associated with SBP-DBP. Previous studies demonstrated that for each 5-mg/dL increment in prolactin, increased odds of low high-density lipoprotein cholesterol were observed in women. In men, a 5-mg/ dL increment was associated with increased risk of incident hypertension and diabetes [73].

To our best knowledge, this is the first GWAS about BMI and BP phenotypes focusing on northern Chinese population. Compared with univariate GWAS, bivariate design could identify more pleiotropic genes to reveal biological mechanisms related to obesity and hypertension. However, there are still some limitations existing. Firstly, the small twin sample due to difficulty in recruitment and restriction in inclusion criteria might be the obstacle to find more significant SNPs, genes and pathways. Secondly, due to lack of standard approach to define the cutoff P value in bivariate GWAS, 5 × 10−8 and 1 ×10−5, which based on Bonferroni correction, were still common used in current GWAS to solve multiple testing problem [74]. Since Bonferroni correction is quite conservative, we applied P <1 ×10−5 as the suggestive association in the discovery stage. However, low P-value threshold might lead to less significant genetic variants caught, thus, more further researches are required to explore the appropriate threshold. Thirdly, since different genetic background and sample size in limited researches, most of our result cannot be verified by other studies. Currently, many risk variants has been revealed associated with obesity and hypertension, however, most of them are lack of direct biological relationship with obesity and hypertension in pathophysiology.

In conclusion, present GWAS identified several SNPs, genes and pathways associated with both BMI and BP. Given there are still uncovered common genetic mechanism potentially related to obesity and hypertension, more studies need to be performed.

Supporting information

S1 Table. Full models and nested models of all traits.

(DOCX)

Click here for additional data file. (17.8KB, docx)
S2 Table. SNPs that reached P < 10–5 from bivariate GWAS of BMI-SBP.

(DOCX)

Click here for additional data file. (15.4KB, docx)
S3 Table. SNPs that reached P < 10–5 from bivariate GWAS of BMI-DBP.

(DOCX)

Click here for additional data file. (15.7KB, docx)
S4 Table. SNPs that reached P < 10–5 from bivariate GWAS of SBP-DBP.

(DOCX)

Click here for additional data file. (15.5KB, docx)
S5 Table. Numbers of significant eQTLs of top 10 genes in interest tissues related to BMI-SBP, BMI-DBP and SBP-DBP.

(DOCX)

Click here for additional data file. (21.4KB, docx)
S6 Table. The top 20 pathway results-KEGG, Reactome, and Biocarta (emp-P < 0.05) for BMI-SBP, BMI-DBP and SBP-DBP.

(DOCX)

Click here for additional data file. (17.6KB, docx)
S1 Fig. Regional association plot showing signal around chromosomal loci of 1q32.1 for bivariate genome-wide association study of BMI-SBP.

(TIF)

Click here for additional data file. (194KB, tif)
S2 Fig. Regional association plot showing signal around chromosomal loci of 13q33.2 for bivariate genome-wide association study of BMI-DBP.

(TIF)

Click here for additional data file. (196.4KB, tif)
S3 Fig. Regional association plot showing signal around chromosomal loci of 5q32 for bivariate genome-wide association study of SBP-DBP.

(TIF)

Click here for additional data file. (207.7KB, tif)

Acknowledgments

We thank Dr. Gu Zhu for his excellent help in technicality.

Data Availability

All SNPs datasets of this study are available from the the European Variation Archive (EVA) (Accession No. PRJEB23749).

Funding Statement

This study was supported by the grants from the National Natural Science Foundation of China (31371024).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet (London, England). 2005;365(9455):217–23. 10.1016/S0140-6736(05)17741-1 [DOI] [PubMed] [Google Scholar]
  • 2.Apovian CM. Obesity: definition, comorbidities, causes, and burden. The American journal of managed care. 2016;22(7 Suppl):s176–85. [PubMed] [Google Scholar]
  • 3.Ninomiya T. Risk of stroke in kidney disease. Contributions to nephrology. 2013;179:58–66. 10.1159/000346724 [DOI] [PubMed] [Google Scholar]
  • 4.Hisham NF, Bayraktutan U. Epidemiology, pathophysiology, and treatment of hypertension in ischaemic stroke patients. Journal of stroke and cerebrovascular diseases: the official journal of National Stroke Association. 2013;22(7):e4–14. [DOI] [PubMed] [Google Scholar]
  • 5.Faraco G, Iadecola C. Hypertension: a harbinger of stroke and dementia. Hypertension (Dallas, Tex: 1979). 2013;62(5):810–7. 10.1161/HYPERTENSIONAHA.113.01063 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.JM F, J N, Jr GR, J S, J C, K E, et al. Blood pressure and mortality among men with prior myocardial infarction. Multiple Risk Factor Intervention Trial Research Group. Circulation. 1995;92(9):2437 10.1161/01.cir.92.9.2437 [DOI] [PubMed] [Google Scholar]
  • 7.Ljutic D, Kes P. The role of arterial hypertension in the progression of non-diabetic glomerular diseases. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association—European Renal Association. 2003;18 Suppl 5:v28-30. 10.1093/ndt/gfg1040 [DOI] [PubMed] [Google Scholar]
  • 8.Global Ng T., regional, and national prevalence of overweight and obesity in children and adults during 1980–2003: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (London, England). 2014;384(9945):766–81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Singh GM, Danaei G, Farzadfar F, Stevens GA, Woodward M, Wormser D, et al. The Age-Specific Quantitative Effects of Metabolic Risk Factors on Cardiovascular Diseases and Diabetes: A Pooled Analysis. PloS one. 2013;8 10.1371/journal.pone.0065174 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Collaboration APCS. Body mass index and cardiovascular disease in the Asia-Pacific Region: an overview of 33 cohorts involving 310 000 participants. International journal of epidemiology. 2004(4):4 10.1093/ije/dyh163 [DOI] [PubMed] [Google Scholar]
  • 11.Singh RK, Kumar P, Mahalingam K. Molecular genetics of human obesity: A comprehensive review. Comptes rendus biologies. 2017;340(2):87–108. 10.1016/j.crvi.2016.11.007 [DOI] [PubMed] [Google Scholar]
  • 12.Pierce TW, Grim RD, King JS. Cardiovascular reactivity and family history of hypertension: A meta-analysis. Psychophysiology. 2010;42(1):125–31. [DOI] [PubMed] [Google Scholar]
  • 13.Kolifarhood G, Daneshpour M, Hadaegh F, Sabour S, Mozafar Saadati H, Akbar Haghdoust A, et al. Heritability of blood pressure traits in diverse populations: a systematic review and meta-analysis. Journal of human hypertension. 2019;33(11):775–85. 10.1038/s41371-019-0253-4 [DOI] [PubMed] [Google Scholar]
  • 14.Elks CE, den Hoed M, Zhao JH, Sharp SJ, Wareham NJ, Loos RJ, et al. Variability in the heritability of body mass index: a systematic review and meta-regression. Frontiers in endocrinology. 2012;3:29 10.3389/fendo.2012.00029 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Davy KP, Hall JE. Obesity and hypertension: two epidemics or one? 2004;286(5):803–13. 10.1152/ajpregu.00707.2003 [DOI] [PubMed] [Google Scholar]
  • 16.Mikhail N, Golub MS, Tuck ML. Obesity and hypertension. Progress in Cardiovascular Diseases. 1999;42(1):39–58. 10.1016/s0033-0620(99)70008-3 [DOI] [PubMed] [Google Scholar]
  • 17.Wu Y, Zhang D, Pang Z, Jiang W, Wang S, Li S, et al. Multivariate modeling of body mass index, pulse pressure, systolic and diastolic blood pressure in Chinese twins. Twin research and human genetics: the official journal of the International Society for Twin Studies. 2015;18(1):73–8. 10.1017/thg.2014.83 [DOI] [PubMed] [Google Scholar]
  • 18.Duan H, Pang Z, Zhang D, Li S, Kruse TA, Kyvik KO, et al. Genetic and environmental dissections of sub-phenotypes of metabolic syndrome in the Chinese population: a twin-based heritability study. Obesity facts. 2011;4(2):99–104. 10.1159/000327735 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Zeegers MP, Rijsdijk F, Sham P, Fagard R, Gielen M, De Leeuw PW, et al. The contribution of risk factors to blood pressure heritability estimates in young adults: the East flanders prospective twin study. Twin Res. 2004;7(3):245–53. 10.1375/136905204774200523 [DOI] [PubMed] [Google Scholar]
  • 20.Wu Y, Duan H, Tian X, Xu C, Wang W, Jiang W, et al. Genetics of Obesity Traits: A Bivariate Genome-Wide Association Analysis. Frontiers in genetics. 2018;9:179 10.3389/fgene.2018.00179 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Wu T, Snieder H, Li L, Cao W, Zhan S, Lv J, et al. Genetic and environmental influences on blood pressure and body mass index in Han Chinese: a twin study. Hypertension research: official journal of the Japanese Society of Hypertension. 2011;34(2):173–9. [DOI] [PubMed] [Google Scholar]
  • 22.Tarnoki AD, Tarnoki DL, Bogl LH, Medda E, Fagnani C, Nistico L, et al. Association of body mass index with arterial stiffness and blood pressure components: a twin study. Atherosclerosis. 2013;229(2):388–95. 10.1016/j.atherosclerosis.2013.05.001 [DOI] [PubMed] [Google Scholar]
  • 23.Duan H, Pang Z, Zhang D, Li S, Kruse TA, Kyvik KO, et al. Genetic and environmental dissections of sub-phenotypes of metabolic syndrome in the Chinese population: a twin-based heritability study. Obesity facts. 2011;4(2):99–104. 10.1159/000327735 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Visscher PM, Montgomery GW. Genome-wide Association Studies and Human Disease. Jama. 2009;302(18):2028 10.1001/jama.2009.1643 [DOI] [PubMed] [Google Scholar]
  • 25.Newton-Cheh C, Johnson T, Gateva V, Tobin MD, Bochud M, Coin L, et al. Genome-wide association study identifies eight loci associated with blood pressure. Nature genetics. 2009;41(6):666–76. 10.1038/ng.361 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Lu X, Wang L, Lin X, Huang J, Charles Gu C, He M, et al. Genome-wide association study in Chinese identifies novel loci for blood pressure and hypertension. Human molecular genetics. 2015;24(3):865–74. 10.1093/hmg/ddu478 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Evangelou E, Warren HR, Mosen-Ansorena D, Mifsud B, Pazoki R, Gao H, et al. Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits. Nature genetics. 2018;50(10):1412–25. 10.1038/s41588-018-0205-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Hoffmann TJ, Ehret GB, Nandakumar P, Ranatunga D, Schaefer C, Kwok PY, et al. Genome-wide association analyses using electronic health records identify new loci influencing blood pressure variation. Nature genetics. 2017;49(1):54–64. 10.1038/ng.3715 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Locke AE, Kahali B, Berndt SI, Justice AE, Pers TH, Day FR, et al. Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015;518(7538):197–206. 10.1038/nature14177 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Zhao W, Rasheed A, Tikkanen E, Lee JJ, Butterworth AS, Howson JMM, et al. Identification of new susceptibility loci for type 2 diabetes and shared etiological pathways with coronary heart disease. Nature genetics. 2017;49(10):1450–7. 10.1038/ng.3943 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Porter HF, O’Reilly PF. Multivariate simulation framework reveals performance of multi-trait GWAS methods. Scientific reports. 2017;7:38837 10.1038/srep38837 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Neupane B, Beyene J. Bivariate linear mixed model analysis to test joint associations of genetic variants on systolic and diastolic blood pressure. BMC proceedings. 2014;8(Suppl 1 Genetic Analysis Workshop 18Vanessa Olmo):S75 10.1186/1753-6561-8-S1-S75 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Huang Y, Ollikainen M, Sipilä P, Mustelin L, Wang X, Su S, et al. Genetic and Environmental Effects on Gene Expression Signatures of Blood Pressure: A Transcriptome-Wide Twin Study. Hypertension (Dallas, Tex: 1979). 2018;71(3):457–64. 10.1161/HYPERTENSIONAHA.117.10527 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Xu C, Zhang D, Tian X, Wu Y, Pang Z, Li S, et al. Genetic and Environmental Basis in Phenotype Correlation Between Physical Function and Cognition in Aging Chinese Twins. Twin Res Hum Genet. 2017;20(1):60–5. 10.1017/thg.2016.98 [DOI] [PubMed] [Google Scholar]
  • 35.Xu C, Zhang D, Tian X, Duan H, Wu Y, Pang Z, et al. Genetic and Environmental Influences on Correlations Between Hearing and Cognitive Functions in Middle and Older Chinese Twins. Twin Res Hum Genet. 2017:1–6. 10.1017/thg.2016.100 [DOI] [PubMed] [Google Scholar]
  • 36.Marchini J, Howie B, Myers S, McVean G, Donnelly P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nature genetics.39(7):906–13. 10.1038/ng2088 [DOI] [PubMed] [Google Scholar]
  • 37.Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, Korbel JO, et al. A global reference for human genetic variation. Nature. 2015;526(7571):68–74. 10.1038/nature15393 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Neale MC, Cardon LR. Methodology for Genetic Studies of Twins and Families: Springer; Netherlands; 1992. [Google Scholar]
  • 39.Rijsdijk FV, Sham PC. Analytic approaches to twin data using structural equation models. Briefings in bioinformatics. 2002;3(2):119–33. 10.1093/bib/3.2.119 [DOI] [PubMed] [Google Scholar]
  • 40.Akaike H. Factor analysis and AIC. Psychometrika. 1987;52(3):317–32. [Google Scholar]
  • 41.Zhou X, Stephens M. Genome-wide efficient mixed-model analysis for association studies. Nature genetics. 2012;44(7):821–4. 10.1038/ng.2310 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Zhou X, Carbonetto P, Stephens M. Polygenic modeling with bayesian sparse linear mixed models. PLoS genetics. 2013;9(2):e1003264 10.1371/journal.pgen.1003264 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science. 1996;273(5281):1516–7. 10.1126/science.273.5281.1516 [DOI] [PubMed] [Google Scholar]
  • 44.Dudbridge F, Gusnanto A. Estimation of significance thresholds for genomewide association scans. Genetic epidemiology. 2008;32(3):227–34. 10.1002/gepi.20297 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Shu R, Pei YF, Liu YJ, Lei Z, Han YY, Rong H, et al. Bivariate Genome-Wide Association Analyses Identified Genes with Pleiotropic Effects for Femoral Neck Bone Geometry and Age at Menarche. PloS one. 2013;8(4):e60362–. 10.1371/journal.pone.0060362 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Loukola A, Wedenoja J, Keskitalo-Vuokko K, Broms U, Korhonen T, Ripatti S, et al. Genome-wide association study on detailed profiles of smoking behavior and nicotine dependence in a twin sample. Molecular psychiatry. 2014;19(5):615–24. 10.1038/mp.2013.72 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Slifer SH. PLINK: Key Functions for Data Analysis. Current protocols in human genetics. 2018;97(1):e59 10.1002/cphg.59 [DOI] [PubMed] [Google Scholar]
  • 48.Nica AC, Dermitzakis ET. Using gene expression to investigate the genetic basis of complex disorders. Human molecular genetics. 2008;17(R2):R129–34. 10.1093/hmg/ddn285 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Gilad Y, Rifkin SA, Pritchard JK. Revealing the architecture of gene regulation: the promise of eQTL studies. Trends in genetics: TIG. 2008;24(8):408–15. 10.1016/j.tig.2008.06.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Ward LD, Kellis M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 2012;40(Database issue):D930–4. 10.1093/nar/gkr917 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.The Genotype-Tissue Expression (GTEx) project. Nature genetics. 2013;45(6):580–5. 10.1038/ng.2653 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Liu JZ, Mcrae AF, Nyholt DR, Medland SE, Wray NR, Brown KM, et al. A Versatile Gene-Based Test for Genome-wide Association Studies.87(1):139–45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Mishra A, Macgregor S. VEGAS2: Software for More Flexible Gene-Based Testing. Twin Research & Human Genetics.18(01):86–91. 10.1017/thg.2014.79 [DOI] [PubMed] [Google Scholar]
  • 54.Xu C, Zhang D, Wu Y, Tian X, Pang Z, Li S, et al. A genome-wide association study of cognitive function in Chinese adult twins. Biogerontology. 2017. 10.1007/s10522-017-9725-5 [DOI] [PubMed] [Google Scholar]
  • 55.Lamparter D, Marbach D, Rueedi R, Kutalik Z, Bergmann S. Fast and Rigorous Computation of Gene and Pathway Scores from SNP-Based Summary Statistics. Plos Computational Biology. 2016;12(1):e1004714 10.1371/journal.pcbi.1004714 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Man T, Nolte IM, Jaju D, Al-Anqoudi ZAM, Munoz ML, Hassan MO, et al. Heritability and genetic correlations of obesity indices with ambulatory and office beat-to-beat blood pressure in the Oman Family Study. Journal of hypertension. 2020. 10.1097/HJH.0000000000002430 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Natarajan R, Reddy MA, Malik KU, Fatima S, Khan BV. Signaling Mechanisms of Nuclear Factor-?B-Mediated Activation of Inflammatory Genes by 13-Hydroperoxyoctadecadienoic Acid in Cultured Vascular Smooth Muscle Cells. Arteriosclerosis, thrombosis, and vascular biology.21(9):1408–13. 10.1161/hq0901.095278 [DOI] [PubMed] [Google Scholar]
  • 58.Yang M, He RL, Benovic JL, Ye RD. beta-Arrestin1 interacts with the G-protein subunits beta1gamma2 and promotes beta1gamma2-dependent Akt signalling for NF-kappaB activation. Biochemical Journal. 2009;417(1):287–96. 10.1042/BJ20081561 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Ségui B, Cuvillier O, Adam-Klages S, Garcia V, Malagarie-Cazenave S, Lévêque S, et al. Involvement of FAN in TNF-induced apoptosis. J Clin Invest. 2001;108(1):143–51. 10.1172/JCI11498 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Montfort A, de Badts B, Douin-Echinard V, Martin PG, Iacovoni J, Nevoit C, et al. FAN stimulates TNF(alpha)-induced gene expression, leukocyte recruitment, and humoral response. Journal of immunology (Baltimore, Md: 1950). 2009;183(8):5369–78. [DOI] [PubMed] [Google Scholar]
  • 61.Fan F, Muroya Y, Roman RJ. Cytochrome P450 eicosanoids in hypertension and renal disease. Curr Opin Nephrol Hypertens. 2015;24(1):37–46. 10.1097/MNH.0000000000000088 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Takeuchi F, Isono M, Katsuya T, Yamamoto K, Yokota M, Sugiyama T, et al. Blood pressure and hypertension are associated with 7 loci in the Japanese population. Circulation. 2010;121(21):2302–9. 10.1161/CIRCULATIONAHA.109.904664 [DOI] [PubMed] [Google Scholar]
  • 63.Tan L, Wang Z, Li Y. Rabbit models provide insights into bone formation related biological process in atherosclerotic vascular calcification. Biochem Biophys Res Commun. 2018;496(4):1369–75. 10.1016/j.bbrc.2018.02.035 [DOI] [PubMed] [Google Scholar]
  • 64.Chambers JC, Loh M, Lehne B, Drong A, Kriebel J, Motta V, et al. Epigenome-wide association of DNA methylation markers in peripheral blood from Indian Asians and Europeans with incident type 2 diabetes: a nested case-control study. The lancet Diabetes & endocrinology. 2015;3(7):526–34. 10.1016/S2213-8587(15)00127-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Dayeh T, Tuomi T, Almgren P, Perfilyev A, Jansson PA, de Mello VD, et al. DNA methylation of loci within ABCG1 and PHOSPHO1 in blood DNA is associated with future type 2 diabetes risk. Epigenetics. 2016;11(7):482–8. 10.1080/15592294.2016.1178418 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Sihvola V, Levonen A-L. Keap1 as the redox sensor of the antioxidant response. Arch Biochem Biophys. 2017;617:94–100. 10.1016/j.abb.2016.10.010 [DOI] [PubMed] [Google Scholar]
  • 67.Pi J, Leung L, Xue P, Wang W, Hou Y, Liu D, et al. Deficiency in the nuclear factor E2-related factor-2 transcription factor results in impaired adipogenesis and protects against diet-induced obesity. J Biol Chem. 2010;285(12):9292–300. 10.1074/jbc.M109.093955 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Igarashi J, Michel T. Agonist-modulated targeting of the EDG-1 receptor to plasmalemmal caveolae. eNOS activation by sphingosine 1-phosphate and the role of caveolin-1 in sphingolipid signal transduction. J Biol Chem. 2000;275(41):32363–70. 10.1074/jbc.M003075200 [DOI] [PubMed] [Google Scholar]
  • 69.Igarashi J, Bernier SG, Michel T. Sphingosine 1-Phosphate and Activation of Endothelial Nitric-oxide Synthase. DIFFERENTIAL REGULATION OF Akt AND MAP KINASE PATHWAYS BY EDG AND BRADYKININ RECEPTORS IN VASCULAR ENDOTHELIAL CELLS. Journal of Biological Chemistry.276(15):12420–6. 10.1074/jbc.M008375200 [DOI] [PubMed] [Google Scholar]
  • 70.Li LX, MacDonald PE, Ahn DS, Oudit GY, Backx PH, Brubaker PL. Role of phosphatidylinositol 3-kinasegamma in the beta-cell: interactions with glucagon-like peptide-1. Endocrinology. 2006;147(7):3318–25. 10.1210/en.2006-0155 [DOI] [PubMed] [Google Scholar]
  • 71.MacDonald PE, Joseph JW, Yau D, Diao J, Asghar Z, Dai F, et al. Impaired glucose-stimulated insulin secretion, enhanced intraperitoneal insulin tolerance, and increased beta-cell mass in mice lacking the p110gamma isoform of phosphoinositide 3-kinase. Endocrinology. 2004;145(9):4078–83. 10.1210/en.2004-0028 [DOI] [PubMed] [Google Scholar]
  • 72.Martinez-Lemus LA, Crow T, Davis MJ, Meininger GA. alphavbeta3- and alpha5beta1-integrin blockade inhibits myogenic constriction of skeletal muscle resistance arterioles. American journal of physiology Heart and circulatory physiology. 2005;289(1):H322–H9. 10.1152/ajpheart.00923.2003 [DOI] [PubMed] [Google Scholar]
  • 73.Therkelsen KE, Abraham TM, Pedley A, Massaro JM, Sutherland P, Hoffmann U, et al. Association Between Prolactin and Incidence of Cardiovascular Risk Factors in the Framingham Heart Study. Journal of the American Heart Association.5(2):e002640 10.1161/JAHA.115.002640 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Xu C, Tachmazidou I, Walter K, Ciampi A, Zeggini E, Greenwood CM. Estimating genome-wide significance for whole-genome sequencing studies. Genetic epidemiology. 2014;38(4):281–90. 10.1002/gepi.21797 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

S1 Table. Full models and nested models of all traits.

(DOCX)

Click here for additional data file. (17.8KB, docx)
S2 Table. SNPs that reached P < 10–5 from bivariate GWAS of BMI-SBP.

(DOCX)

Click here for additional data file. (15.4KB, docx)
S3 Table. SNPs that reached P < 10–5 from bivariate GWAS of BMI-DBP.

(DOCX)

Click here for additional data file. (15.7KB, docx)
S4 Table. SNPs that reached P < 10–5 from bivariate GWAS of SBP-DBP.

(DOCX)

Click here for additional data file. (15.5KB, docx)
S5 Table. Numbers of significant eQTLs of top 10 genes in interest tissues related to BMI-SBP, BMI-DBP and SBP-DBP.

(DOCX)

Click here for additional data file. (21.4KB, docx)
S6 Table. The top 20 pathway results-KEGG, Reactome, and Biocarta (emp-P < 0.05) for BMI-SBP, BMI-DBP and SBP-DBP.

(DOCX)

Click here for additional data file. (17.6KB, docx)
S1 Fig. Regional association plot showing signal around chromosomal loci of 1q32.1 for bivariate genome-wide association study of BMI-SBP.

(TIF)

Click here for additional data file. (194KB, tif)
S2 Fig. Regional association plot showing signal around chromosomal loci of 13q33.2 for bivariate genome-wide association study of BMI-DBP.

(TIF)

Click here for additional data file. (196.4KB, tif)
S3 Fig. Regional association plot showing signal around chromosomal loci of 5q32 for bivariate genome-wide association study of SBP-DBP.

(TIF)

Click here for additional data file. (207.7KB, tif)

Data Availability Statement

All SNPs datasets of this study are available from the the European Variation Archive (EVA) (Accession No. PRJEB23749).

Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES